Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure

International Journal of Cardiology

Volumn 104, Issue 1, 2005, Pages 39-45

  Passino, Claudio ^a   Sironi, Anna Maria ^a   Favilli, Brunella ^a   Poletti, Roberta ^a   Prontera, Concetta ^a   Ripoli, Andrea ^a   Lombardi, Massimo ^a   Emdin, Michele ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Heart failure; Hormones; Magnetic resonance imaging; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BODY SURFACE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HEART VOLUME; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIASTOLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 24044455714     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.09.008     Document Type: Article

References (28)

1. H.H. Chen, and J.C. Burnett The natriuretic peptides in heart failure: diagnostic and therapeutic potentials Proc. Assoc. Am. Physicians 111 1999 406 416
2. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
3. B.A. Groenning, J.C. Nilsson, L. Sondergaard, A. Kjaer, H.B. Larsson, and P.R. Hildebrandt Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations Eur. J. Heart Fail. 3 2001 699 708
4. B.A. Groenning, J.C. Nilsson, L. Sondergaard, F. Pedersen, J. Trawinski, and M. Baumann Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations Am. Heart J. 143 2002 923 929
5. T.G. Di Salvo, M. Mathier, M.J. Semigran, and G.W. Dec Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J. Am. Coll. Cardiol. 25 1995 1143 1153
6. S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, and R. Sebastiani Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J. Am. Coll. Cardiol. 37 2001 183 188
7. P. de Groote, A. Millaire, C. Foucher-Hossein, O. Nugue, X. Marchandise, and G. Ducloux Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J. Am. Coll. Cardiol. 32 1998 948 954
8. Y. Juilliere, G. Barbier, L. Feldmann, A. Grentzinger, N. Danchin, and F. Cherrier Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy Eur. Heart J. 18 1997 276 280
9. L.A. Zornoff, H. Skali, M.A. Pfeffer, M. St John Sutton, J.L. Rouleau, G.A. Lamas SAVE Investigators Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction J. Am. Coll. Cardiol. 39 2002 1450 1455
10. M. Pfisterer, H. Emmenegger, M. Soler, and F. Burkart Prognostic significance of right ventricular ejection fraction for persistent complex ventricular arrhythmias and/or sudden cardiac death after first myocardial infarction: relation to infarct location, size and left ventricular function Eur. Heart J. 7 1986 289 298
11. E. Nagel, R. Underwood, D. Pennell, U.P. Sechten, S. Neubauers, and S. Wickline New developments in non-invasive cardiac imaging: critical assessment of the clinical role of cardiac magnetic resonance imaging Eur. Heart J. 19 1998 1286 1293
12. A. Clerico, G. Iervasi, M.G Del Chicca, M. Emdin, S. Maffei, and M. Nannipieri Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure J. Endocrinol. Invest. 21 1998 170 179
13. A. Clerico, S. Del Ry, S. Maffei, C. Prontera, M. Emdin, and D. Giannessi The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex Clin. Chem. Lab. Med. 40 2002 371 377
14. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
15. R.W. Platt, J.A. Hanley, and H. Yang Bootstrap confidence intervals for sensitivity of a quantitative diagnostic test Stat. Med. 19 2000 313 322
16. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. vonScheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J. Am. Coll. Cardiol. 38 2001 1934 1941
17. A. Clerico, and M. Emdin Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review Clin. Chem. 50 2004 33 50
18. L.K. Morrison, A. Harrison, P. Krishnaswamy, R. Kazanegra, P. Clopton, and A. Maisel Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J. Am. Coll. Cardiol. 39 2002 202 209
19. P.A. McCullough, R.M. Nowak, J. McCord, J.E. Hollander, H.C. Herrmann, and P.G. Steg B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study Circulation 106 2002 416 422
20. K.L. Baughman B-type natriuretic peptide-a window to the heart N. Engl. J. Med. 347 2002 158 159
21. A. Clerico, G. Iervasi, and A. Pilo Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations Curr. Drug Metab. 1 2000 85 105
22. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, and M. Jougasaki Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
23. K. Hosoda, K. Nakao, M. Mukoyama, Y. Saito, M. Jougasaki, and G. Shirakami Expression of brain natriuretic peptide gene in human heart. Production in the ventricle Hypertension 17 1991 1152 1155
24. N. Nagaya, T. Nishikimi, Y. Okano, M. Uematsu, T. Satoh, and S. Kyotani Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J. Am. Coll. Cardiol. 31 1998 202 208
25. I.I. Tulevski, M. Groenink, E.E. van Der Wall, D.J. van Veldhuisen, F. Broomsma, and J. Stoker Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction Heart 86 2001 27 30
26. D. Mariano-Goulart, M.C. Eberle, V. Boudousq, A. Hejazi-Moughari, C. Piot, and C. Caderas de Kerleau Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure Eur. J. Heart Fail. 5 2003 481 488
27. C.G. Missouris, E. Grouzmann, M.G. Buckley, J. Barron, G.A. MacGregor, and D.R. Singer How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines Clin. Sci. 94 1998 591 599
28. J.E. Sanderson, W.W. Chan, Y.T. Hung, S.K. Chan, I.O. Shum, and K. Raymond Effect of low dose beta-blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker Br. Heart J. 74 1995 502 507